Tuesday, 19 Jun 2018

RA/Inflammatory arthritis

Datesort ascending Type Title Save
13 Jun 2018 Social RT @StefanSiebert1: Gravallese, US: Teriparatide (PTH) increased BMD but no effect on erosions in #rheumatoid #arthritis. Another example w…
13 Jun 2018 Social RT @RonanTKavanagh: Kaine. Temporary discontinuation of toficitinab for RA (mean 19 days) after treatment >= 4 months does not result in l…
13 Jun 2018 Social RT @StefanSiebert1: We have seen worsening inflammatory arthritis following vedolizumab for IBD https://t.co/jSnaCIpWW0
13 Jun 2018 Social 3190 Stroke or TIA patients were followed, 638 with RA and 2552 without RA- Those w RA were at significantly increased risk for recurrent stroke and TIA - especially amongst smokers. https://t.co/SqWZ6e9bY1
08 Jun 2018 Social Olumiant will be 60% less than TNF inhibitors, and will carry a list price of around $25,000 a year.
07 Jun 2018 Social Although the mean age at death was higher in GCA than nl population, death in GCA is associated with aortic aneurysm/dissection (SMOR: 3.1), HTN (SMOR: 2.2), DM (1.96), Infection (1.76) & ischemic heart dz (1.45). https://t.co/DYbdDgnJEB
06 Jun 2018 Social RT @MattieRheumMD: Interesting to see how PBMs handle Lilly’s new Jak inhibitor,Olumiant priced @ 60% less than the top anti-Tnf. It is als…
06 Jun 2018 Social Metanalysis of 71 RCTs of biologics vs DMARDs in 23,535 RA patients failed to show a significant or meaninful effect of biologics (vs DMARDs) on mental health outcomes and that integrated mental health care may be necessary. https://t.co/pAxZVXwvhL
06 Jun 2018 Social Abbvie announced resultes of its SELECT EARLY study of MTX vs upadacitinib monotherapy in MTX-naïve RA pts. Wk 24 ACR 20 was MTX=59% and UPA 78-79%; ACR70 MTX=16% vs UPA=44-50%. UPA had less VTE than MTX. https://t.co/xKBQQ96kVX
05 Jun 2018 Social Quick review of the package insert details with the new RA drug baricitinib (Olumiant) https://t.co/cERR5HWr7Y
04 Jun 2018 Social Study of preclinical samples from 83 subsequent RA pts shows that double positivity (RF+ ACPA+) is associated with higher levels of proinflammatory cytokines and more rapid progression to develop #RA. https://t.co/b7zwDHAqkd
04 Jun 2018 News FDA Approves Low Dose Baricitinib for Rheumatoid Arthritis
03 Jun 2018 Social ⋆ TOP TWEET FDA approves Lilly's baricitinib (Olumiant) at the lower dose of 2 mg qd for adults with moderate-to-severe active rheumatoid arthritis who are refractory to TNF inhib. Mono or comb w/ DMARD. Boxed warnings for serious infections, Cancer, VTE https://t.co/IqUt9PEysD
02 Jun 2018 Social RheumNow Wk in Review is up. Good news for GPA w/ Renal transplant, Early RA challenges, Vaccinots and HPV and the risk of cancer in PsA. Check out the podcast https://t.co/nqif5yPBx9 or the website video https://t.co/bj6ar7ZlYT
01 Jun 2018 News FDA Approves Baricitinib 2 mg for Rheumatoid Arthritis
01 Jun 2018 Social German longitudinal study of 953 JIA pts shows that 3 years after Dx 75% achieve improvement and quality of life equal to their non-arthritic normal controls https://t.co/pwUzx5iIx7
31 May 2018 Slide of the day Swollen Hands In Rheumatoid Arthritis
31 May 2018 Social 43 yoM case of dermatomyositis-prox weakness, arthralgia, classic DM rashes. High CK, abnl EMG. Dx confirmed by skin & muscle Bx & +PM-Scl(75), MDA5 & SRP Abs; Despite mild weakness he died w/ progressive ILD, typical of MDA5. https://t.co/aEBEOqXf1S
30 May 2018 Social Retrospective study shows exposure to vapour, gas, dust and fumes (VGDF) increases risk of RF (not ACPA) positivity. Combined smoking and and VDGF exposure increases risk of RF and lower age of RA diagnosis than smokers with no VGDF exposure https://t.co/J1gmMMbjTU
30 May 2018 News Increased Risk of Depression and Anxiety in Rheumatoid Arthritis